TXG
TXG
US88025U1097
10x Genomics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
10.51B EUR
5B EUR
2.74B EUR
2.08B EUR
Enterprise Value
9.6B EUR
4.57B EUR
2.33B EUR
1.69B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
1,051.91x
--
--
--
Price to Sales
17.03x
8.1x
4.29x
4.27x
Price to Book
12.73x
6.05x
3.36x
2.62x
EV/Revenue
15.55x
7.41x
3.65x
3.47x
EV/EBITDA
-232.9x
163x
52.51x
34.2x
Price to FCF (P/FCF)
58.49x
41.13x
22.41x
21.33x
EV/FCF
53.41x
37.64x
19.07x
17.34x
FCF Yield
1.71%
2.43%
4.46%
4.69%
ende